Bernard J. Zovighian, CEO at Edwards Lifesciences Corp (EW), sold 89,189 shares at $78.40 ($4.9M) on 2026-05-12, disclosed to the SEC on 2026-05-12.
Scheduled sale ($4.9M) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.96 | 26,198 | $2.1M | 42.5% |
| 2 | $0.00 | 26,640 | $0 | 0.0% |
| 3 | $77.92 | 35,506 | $2.8M | 56.1% |
| 4 | $78.40 | 845 | $66K | 1.3% |
| Total | $55.25 avg | 89,189 | $4.9M | 100% |
| Filing → |
| EW | SELL | 2026-02-13 | $3.4M | — | Filing → |
| EW | SELL | 2025-12-10 | $4.3M | — | Filing → |
| EW | SELL | 2025-06-03 | $2.6M | — | Filing → |